We are live on ! Find out more
ASPX

AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX

Delisted

ASPX was delisted on the 4th of May, 2015.

Back to rankings

0 hedge funds and large institutions have $0 invested in AUSPEX PHARMACEUTICALS INC COM STK (DE) in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 138 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 138 → 0 (-138)

100% less funds holding in top 10

Funds holding in top 10: 9 → 0 (-9)

100% less capital invested

Capital invested by funds: $1.91B → $0 (-$1.91B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 138

Holders
–
Holders Change
-138
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
138
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$446M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$180M
3
Millennium Management
Millennium Management
New York
-$116M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$88.5M
5
BFA
BlackRock Fund Advisors
California
-$67.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
76
ALPS Advisors
Colorado
– -$1.52M -15,173 Closed
HA
77
Havens Advisors
New York
– -$1.51M -15,000 Closed
KAM
78
Kassirer Asset Management
Ontario, Canada
– -$1.5M -15,000 Closed
WMSA
79
Weiss Multi-Strategy Advisers
New York
– -$1.5M -15,000 Closed
AllianceBernstein
80
AllianceBernstein
Tennessee
– -$1.44M -14,400 Closed
DekaBank Deutsche Girozentrale
81
DekaBank Deutsche Girozentrale
Germany
– -$1.44M -14,400 Closed
Citigroup
82
Citigroup
New York
– -$1.33M -13,231 Closed
WAM
83
Wolverine Asset Management
Illinois
– -$1.25M -12,500 Closed
TAM
84
Tocqueville Asset Management
New York
– -$1.22M -12,150 Closed
SG Americas Securities
85
SG Americas Securities
New York
– -$1.22M -12,140 Closed
GC
86
Guggenheim Capital
Illinois
– -$1.18M -11,727 Closed
HHC
87
Hutchin Hill Capital
New York
– -$1.05M -10,451 Closed
PAMP
88
Polar Asset Management Partners
Ontario, Canada
– -$1M -10,000 Closed
RhumbLine Advisers
89
RhumbLine Advisers
Massachusetts
– -$992K -9,890 Closed
HCM
90
Harvey Capital Management
Florida
– -$977K -9,750 Closed
BC
91
Birchview Capital
Vermont
– -$902K -9,000 Closed
NFA
92
Nationwide Fund Advisors
Ohio
– -$884K -8,815 Closed
Connor, Clark & Lunn Investment Management (CC&L)
93
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$832K -8,300 Closed
MLICM
94
Metropolitan Life Insurance Company (MetLife)
New York
– -$807K -8,049 Closed
OAM
95
Orinda Asset Management
California
– -$802K -8,000 Closed
AC
96
Andromeda Capital
New York
– -$769K -7,674 Closed
Manulife (Manufacturers Life Insurance)
97
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$713 -7,113 Closed
UBS AM
98
UBS AM
Illinois
– -$702K -7,000 Closed
NSEDCP
99
NJ State Employees Deferred Compensation Plan
New Jersey
– -$662K -6,600 Closed
Group One Trading
100
Group One Trading
Illinois
– -$652K -6,500 Closed
2 3
4
5 6

ASPX Hedge Fund Activity: Q2 2015 in Review

0 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q2 2015, worth a combined $0 — down 100% from $1.91B a quarter earlier.

Sellers outnumbered buyers: 138 funds closed out of ASPX and 0 opened new positions — a net loss of 138 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Deerfield Management, exiting entirely with an estimated $446M sold.

  • 0 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q2 2015, down from 138 in Q1 2015.
  • Funds reported $0 of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q2 2015, down 100% quarter-over-quarter.
  • 0 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q2 2015 and 138 closed out, a net change of -138 holders.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) seller in Q2 2015 was Deerfield Management, an estimated $446M sold.

Based on aggregated 13F filings for Q2 2015.